glp-1 7-36 GLP-1(7-36)amide(human,bovine,guineapig,mouse,rat)|GLP-1(7-36)amide(P1269), CasNo.107444-51-9 Xiamen Jenny Chemical Technology Co., Ltd. China (Mainland) Glucagon-like Peptide-1 (GLP-1) (7-36) /

Description

It not only successfully regulates blood sugar levels [1] but also reduces the appetite and, thereby, the weight of patients [2], especially in individuals with obesity and type 2 diabetes mellitus (T2DM)

There is also an increased need for patient education around dosing and titration

Does the Medicare Bridge Program count toward my Part D deductible or out-of-pocket maximum

If you are uncomfortable with the current valuations of LLY and NVO (dont be, theyre fine), I would recommend looking into more downstream effects where tailwinds provided by these drugs may not be priced in to expectations by the market and/or consensus estimates yet

Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range